IL6 and prostate cancer: A study by Deep et al. illustrated that hiTDExs released by human prostate cancer cells under hypoxic conditions are loaded with higher MMP (2 and 9) proteins as well as several other growth factors and cytokines (TNF1α, TGFβ, and interleukin 6), and thereby induced PMN formation.